Navigation Links
Vaccine shows therapeutic promise against advanced melanoma
Date:6/1/2009

ORLANDO - A vaccine for one of the most lethal cancers, advanced melanoma, has shown improved response rates and progression-free survival for patients when combined with the immunotherapy drug, Interleukin-2, according to researchers from The University of Texas M. D. Anderson Cancer Center.

The findings, presented today at the American Society of Clinical Oncology (ASCO), mark the first vaccine study in the disease - and one of the first in cancer overall - to show clinical benefit in a randomized Phase III clinical trial. Patrick Hwu, M.D., professor and chair of M. D. Anderson's Department of Melanoma Medical Oncology, presented the findings on ASCO's press program.

According to the American Cancer Society, melanoma has one of the fastest growing incidence rates of all cancers. In 2009, more than 68,720 people in the U.S. are projected to be diagnosed with melanoma and 8,650 will likely die from the disease. The five-year survival rates for those with regional and metastatic disease are 65 percent and 16 percent, respectively.

"Obviously, this is a disease, in its advanced setting, in need of better therapies for our patients," said Hwu, a co-investigator on the study. "While more follow up is needed, this study serves as a proof-of-principle for vaccines' role in melanoma and in cancer therapy overall. If we can use the body's own defense system to attack tumor cells, we provide a mechanism for ridding the body of cancer without destroying healthy tissue."

During their tenure at the National Cancer Institute (NCI), Hwu and Douglas Schwartzentruber, M.D., who is currently medical director of the Goshen Center for Cancer Care, were involved in the vaccine's development and early basic and clinical studies. The peptide vaccine, known as gp100:209-217 (200M), works by stimulating patients' T cells, known for controlling immune responses.

"This vaccine activates the body's cytotoxic T cells to recognize antige
'/>"/>

Contact: Laura Sussman
lsussman@mdanderson.org
832-264-8893
University of Texas M. D. Anderson Cancer Center
Source:Eurekalert  

Page: 1 2 3

Related medicine news :

1. DNA vaccine against multiple sclerosis appears safe, potentially beneficial
2. HPV vaccine does not appear to be effective for treating pre-existing HPV infection
3. Vaccine Stops Alzheimers Brain Tangles
4. Human Papilloma Virus vaccines may decrease chances of oral cancer
5. U.S. Teens Fall Short on Vaccine Coverage
6. Nasal Anthrax Vaccine Proves Effective in Animal Study
7. Hot ice, measuring depression, perfect invisibility and flu vaccine incentives
8. Bioniche Receives $2 Million Government Grant For Market Development Related to its E. coli O157:H7 Cattle Vaccine
9. Iomai Patch-Based Vaccine Cut Rate of Travelers Diarrhea by 75 Percent in Phase 2 Field Study
10. FDA approves expanded label for FluMist (influenza virus vaccine live, intranasal) to include childr
11. MedImmune Licenses Reverse Genetics Technology to GlaxoSmithKline for Use in Influenza Vaccine Development and Production
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Vaccine shows therapeutic promise against advanced melanoma
(Date:4/18/2014)... discovery that turns 160 years of neuroanatomy on its ... to be essential for the fast transmission of impulses ... ubiquitous as thought, according to a new work lead ... Institute (HSCI) and the University,s Department of Stem Cell ... of Harvard,s Department of Molecular and Cellular Biology. , ...
(Date:4/18/2014)... Two Simon Fraser University psychologists have made a ... treatment of attention-deficit disorders. , This discovery opens ... may hinder or suppress a specific brain activity ... prevent distraction. , The Journal of Neuroscience ... discovery by John McDonald, an associate professor of ...
(Date:4/17/2014)... inflammation in benign prostate tissue was associated with ... was found even in those with low prostate-specific ... in Cancer Epidemiology, Biomarkers & Prevention , ... Research. , An analysis of prostate tissue biopsies ... of the Prostate Cancer Prevention Trial (PCPT) found ...
(Date:4/17/2014)... vaccine brands for children may not be the most ... factors when choosing vaccines, driving the market toward what ... new study by University of Illinois researchers. , "The ... numerous factors," says Sheldon H. Jacobson, a co-author of ... of mathematics at the U. of I. "In an ...
(Date:4/17/2014)... (April 17, 2014) Two recent papers by ... and colleagues may help scientists develop treatments or ... fever, Japanese encephalitis and other disease-causing flaviviruses. , ... and molecular genetics at the School of Medicine ... Hughes Medical Institute, and colleagues recently published articles ...
Breaking Medicine News(10 mins):Health News:Finding turns neuroanatomy on its head 2Health News:Finding turns neuroanatomy on its head 3Health News:Scientists discover brain's anti-distraction system 2Health News:Chronic inflammation may be linked to aggressive prostate cancer 2Health News:Chronic inflammation may be linked to aggressive prostate cancer 3Health News:Study recalculates costs of combination vaccines 2Health News:CU researchers discover target for treating dengue fever 2
... Cheresh, PhD, professor of pathology at the University of ... for translational research at the Moores UCSD Cancer Center, ... Award, the highest prize bestowed by the Metastasis Research ... involving metastasis. Cheresh was honored at a recent ...
... study published in the Journal of Sexual Medicine ... experience sexual problems after breast cancer. The results showed ... approximately two years post diagnosis. Mary Panjari, PhD, of ... the sexual well-being nearly two years after diagnosis and ...
... into the hearts of patients who have severe aortic stenosis ... has been found to both save lives and improve the ... to be published online at 2 p.m. Pacific time today ... The study will also be presented at 8 a.m. Pacific ...
... By Serena Gordon HealthDay Reporter , ... and Drug Administration on Wednesday approved the first oral ... system disorder that has traditionally been treated with injectable ... and delay the progression of debilitating symptoms in patients ...
... By Steven Reinberg HealthDay Reporter , WEDNESDAY, ... sick to withstand surgery to treat a narrowed aortic valve, ... alive, researchers say. As many as 300,000 Americans suffer ... valve from fully opening and sending blood back into the ...
... 21, 2010 Chicago The prevalence of periodontal ... than originally estimated. Research published in the Journal ... Control and Prevention (CDC) and the American Academy of ... may have been underestimated by as much as 50 ...
Cached Medicine News:Health News:David Cheresh receives top award for cancer metastasis research 2Health News:New treatment for severe aortic stenosis shown to save lives, Stanford researchers say 2Health News:New treatment for severe aortic stenosis shown to save lives, Stanford researchers say 3Health News:FDA Approves 1st Oral Drug to Reduce MS Relapses 2Health News:FDA Approves 1st Oral Drug to Reduce MS Relapses 3Health News:New Procedure for Aortic Valve Replacement Looks Promising 2Health News:New Procedure for Aortic Valve Replacement Looks Promising 3Health News:Gum disease found to be significant public health concern 2
(Date:1/14/2014)... 14, 2014 The Brandeis Medical Center, led by Dr. ... premier and affordable laser tattoo removal experience with the advanced Astanza ... in providing high quality cosmetic services with cutting edge medical technology ... Southern California has seen a dramatic increase in ...
(Date:1/14/2014)... Animal Emergency Critical Care, a LifeCentre partner practice, located at ... is the first in Loudoun County to ... Susan M. Barnes , Medical Director, is a well-seasoned veterinarian ... Cole Taylor , are avid scuba divers. "As altitude skiers and ...
(Date:1/14/2014)... 2014   Oligomerix, Inc. , a privately held company ... disease (AD) and related neurodegenerative disorders, announced today the ... NY as of January 15, 2014 and ... York Medical College. Oligomerix, which is focused ...
Breaking Medicine Technology:Beverly Hills Physician Features Tattoo Removal with the Astanza Duality Laser, Offers $99 Special 2Hyperbaric Veterinary Medicine (hvm) Announces Animal Emergency Critical Care Installs A Small Animal Hyperbaric Chamber 2Oligomerix Relocates Corporate Headquarters and Secures Additional Laboratory Space from New York Medical College 2
... , , PRINCETON, N.J. , ... (Soligenix or the Company), a late-stage biotechnology company, announced today ... which addresses its Lipid Polymer Micelle (LPM™) technology for the ... patent, HK 1071054, entitled "Stabilized Reverse Micelle Compositions and ...
... , , SANTA ROSA, Calif. , ... has completed its first Osseoplasty™ procedures in Europe . The ... its European distributor MBA Incorporado, SL, the largest independent medical device ... begin in the next weeks in the United Kingdom , ...
Cached Medicine Technology:Soligenix Announces Issuance of Hong Kong Patent for its LPM(TM) Oral Drug Delivery Technology 2Soligenix Announces Issuance of Hong Kong Patent for its LPM(TM) Oral Drug Delivery Technology 3Soligenix Announces Issuance of Hong Kong Patent for its LPM(TM) Oral Drug Delivery Technology 4Soligenix Announces Issuance of Hong Kong Patent for its LPM(TM) Oral Drug Delivery Technology 5Osseon Launches in Europe 2
... Density, multi-frequency, linear flexible laparoscopic ... the UST-5536, this "Omni-Plane transducer ... horizontally as well as pivots ... that target lesions can be ...
Super High Density, multi-frequency, end-fire phased array transducer. Point-and-shoot scanning is the benefit of this transducer....
This is a 3D transducer for endovaginal imaging in OB/GYN....
This is a 3D transducer for endovaginal imaging in OB/GYN....
Medicine Products: